RT Journal Article
SR Electronic
T1 Persistence of SARS-CoV-2 in the first trimester placenta leading to vertical transmission and fetal demise from an asymptomatic mother
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.18.20177121
DO 10.1101/2020.08.18.20177121
A1 Prajakta Shende
A1 Pradip Gaikwad
A1 Manisha Gandhewar
A1 Pawankumar Ukey
A1 Anshul Bhide
A1 Vainav Patel
A1 Sharad Bhagat
A1 Vikrant Bhor
A1 Smita Mahale
A1 Rahul Gajbhiye
A1 Deepak Modi
YR 2020
UL http://medrxiv.org/content/early/2020/08/21/2020.08.18.20177121.abstract
AB Coronaviruses infect the respiratory tract and are known to survive in these tissues during the clinical course of infection. However, how long can SARS-CoV-2 survive in the tissues is hitherto unknown. Herein, we report a case where the virus is detected in the first trimester placental cytotrophoblast and syncytiotrophoblasts five weeks after the asymptomatic mother cleared the virus from the respiratory tract. This first trimester placental infection was vertically transmitted as the virus was detected in the amniotic fluid and fetal membranes. This congenitally acquired SARS-CoV-2 infection was associated with hydrops and fetal demise. This is the first study providing concrete evidences towards persistent tissue infection of SARS-CoV-2, its congenital transmission in early pregnancy leading to intrauterine fetal death.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study is a case report and not a clinical trialFunding StatementNo specific funding was received fro this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institute Ethics committee of ESI- PGIMSR and Model Hospital, Mumbai from where the case is reportedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data is available from the authors upon request